| Turcja | Austria | Hiszpania | |
| Leczenie komórkami macierzystymi | od $8,000 | od $8,500 | od $8,500 |
| Leczenie SLA (stwardnienia zanikowego bocznego) komórkami macierzystymi | od $30,000 | od $60,000 | od $40,000 |
Turkey is a key destination for Amyotrophic Lateral Sclerosis (ALS) treatment, with hospitals like Liv Hospital Ulus, NP Istanbul Brain Hospital, and Medipol Mega University Hospital offering advanced care. These institutions are accredited by the Joint Commission International, ensuring high standards of healthcare quality.
Medipol Mega University Hospital features technologies like the Da Vinci Surgical System and CyberKnife, facilitating precise procedures. These hospitals lead in ALS treatments such as stem cell therapy and gene therapy. ALS survival rates in Turkey are improving, reflecting the effectiveness of early diagnosis and personalized care.
Germany leads in Amyotrophic lateral sclerosis (ALS) treatment, with top clinics like Asklepios Hospital Barmbek, Medical Center in Solingen, and Asklepios St. Georg Hospital. Asklepios Hospital Barmbek is a preferred choice for international patients per the Medical Travel Quality Alliance. The Medical Center in Solingen is accredited by the German Cancer Society, ensuring high patient care standards.
ALS treatment includes gene therapy, stem cell therapy, neuroprotective agents, and advanced respiratory care. Germany's ALS treatment success and survival rates are promising, with ongoing research and trials. The survival rate for ALS patients in Germany shows improvement due to early diagnosis and innovative strategies, with improved survival rates observed. Facilities like Asklepios St. Georg Hospital are involved in developing new therapies.
Spain is leading in ALS treatment with top institutions like Hospital Quiron Barcelona, Quironsalud Madrid, and SJD Barcelona Children’s Hospital. Quironsalud Madrid actively engages in clinical trials, providing access to new treatments, while SJD Barcelona focuses on pediatric care and molecular medicine. Hospital Quiron Barcelona, accredited by the Joint Commission International, offers advanced diagnostics with PET-CT and MRI.
Innovative procedures like stem cell and gene therapy, alongside neuroprotective drugs, are enhancing ALS treatment success in Spain. The survival rate for ALS patients is steadily improving, driven by personalized care and multidisciplinary approaches. Spanish clinics focus on both physical and psychological needs, reflecting a commitment to research and innovation in ALS care.
Poland is advancing in ALS treatment, with institutions like the University Hospital in Krakow leading in comprehensive care. The Health Clinic “Pod Tezniami” focuses on rehabilitation, while the John Paul II Western Hospital in Grodzisk Mazowiecki excels in cutting-edge treatment.
Innovations such as stem cell therapy, gene therapy, and neuroprotective drug trials are improving outcomes. The survival rate for ALS in Poland is rising due to these treatments. The Centrum Monitorowania Jakości w Ochronie Zdrowia supports quality healthcare, ensuring high standards in ALS centers.
Israel excels in Amyotrophic lateral sclerosis (ALS) treatment, with leading centers like Sourasky Medical Center (Ichilov), Hadassah Medical Center, and Assuta Medical Center accredited by the Joint Commission International. Sourasky Medical Center is globally recognized for its multidisciplinary approach, boasting a 90% success rate in oncology treatments and treating over 400,000 patients annually.
Hadassah Medical Center serves over 1,000,000 patients yearly, excelling in neurosurgery, orthopedics, and oncology. Assuta Medical Center, Israel's largest private hospital, specializes in surgery, IVF, and cardiology. Innovative ALS treatments in Israel include stem cell therapy, gene therapy, and advanced neurorehabilitation techniques. For more on ALS therapies, see Frontiers in Neurology.